Trial Profile
Second registration study of Oraxol
Status:
Planning
Phase of Trial:
Phase III
Latest Information Update: 17 Dec 2015
Price :
$35
*
At a glance
- Drugs Encequidar+paclitaxel (Primary)
- Indications Breast cancer
- Focus Registrational; Therapeutic Use
- 17 Dec 2015 New trial record